HEMOLYTIC STREPTOCOCCIC ANGINA WITH AGRANULOCYTOSIS TREATED WITH PRONTOSIL AND SULPHANILAMIDE
Authors: R. F. Ives
Journal: Annals of Internal Medicine (1938)

Case Reports1 December 1938HEMOLYTIC STREPTOCOCCIC ANGINA WITH AGRANULOCYTOSIS TREATED WITH PRONTOSIL AND SULPHANILAMIDER. F. IVES, M.D., F.A.C.P.R. F. IVES, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-12-6-882 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe fundamental discovery by Domagk1-4of the protective action of certain sulphonamide derivatives of the azo dyes in experimental hemolytic streptococcic infection, and the supplementary demonstration by Tréfouel, Tréfouel, Nitti, and Bovet5of the similar action of para-aminobenzenesulphonamide, have received abundant confirmation.6-13From the date of Domagk's original publication1an ever increasing volume of clinical reports has been appearing in the current medical periodicals concerning the favorable influence of these chemotherapeutic agents in the treatment of the various types of hemolytic streptococcic infection. This literature has contained scattered references to the therapeutic results obtained in the treatment of acute pharyngitis,...References1. DOMAGK G: Ein Beitrag zur Chemotherapie der bakteriellen Infektionen, Deutsch. med. Wchnschr., 1935, lxi, 25-253. Google Scholar2. HÖRLEIN H: The chemotherapy of infectious diseases caused by protozoa and bacteria, Proc. Roy. Soc. Med., 1935, xxix, 313-324. Google Scholar3. DOMAGK G: Chemotherapie der bakteriellen Infektionen, Angew. Chem., 1935, xlviii, 657-667. CrossrefGoogle Scholar4. DOMAGK G: Chemotherapie der Streptokokken-Infektionen, Klin. Wchnschr., 1936, xv, 1585-1590. CrossrefGoogle Scholar5. TRÉFOUELTRÉFOUELNITTIBOVET JJFD: Activité du p-amino-phénylsulfamide sur les infections streptococciques expérimentales de la souris et du lapin, Compt. rend. Soc. biol., 1935, cxx, 756-758. Google Scholar6. LEVADITIVAISMAN CA: Action curative et préventive du chlorhydrate de 4′-sulfamido-2, 4-diaminoazobenzène et de quelques dérivés similaires dans la streptococcie expérimentale, Compt. rend. Acad. d. sci., 1935, cc, 1694-1696; Compt. rend. Soc. de biol., 1935, cxix, 949-951; Presse méd, 1935, xliii, 2097-2102. Google Scholar7. NITTIBOVET FD: Action du 4-sulfonamide-2-4 diaminobenzol (Prontosil) sur des infections streptococciques de la souris provoquées par des streptocoques d'origine humaine, Compt. rend. Soc. de biol., 1935, cxix, 1277-1280. Google Scholar8. GOISSEDETDESPOISGAILLIOTMAYER PRPR: De l'action du radical sulfamide: SO2NH2 sur l'infection streptococcique expérimentale de la souris, Compt. rend. Soc. de biol., 1936, cxxi, 1082-1084. Google Scholar9. COLEBROOKKENNY LM: Treatment of human puerperal infections, and of experimental infections in mice, with prontosil, Lancet, 1936, ccxxx, 1279-1286. CrossrefGoogle Scholar10. BUTTLEGRAYSTEPHENSON GAWHD: Protection of mice against streptococcal and other infections by p-aminobenzenesulphonamide and related substances, Lancet, 1936, ccxxx, 1286-1290. CrossrefGoogle Scholar11. COLEBROOKBUTTLEO'MEARA LGARA: The mode of action of p-aminobenzenesulphonamide and prontosil in hemolytic streptococcal infections, Lancet, 1936, ccxxxi, 1323-1326. CrossrefGoogle Scholar12. LONGBLISS PHEA: Para-aminobenzenesulfonamide and its derivatives: experimental and clinical observations on their use in the treatment of beta hemolytic streptococcic infections, Jr. Am. Med. Assoc., 1937, cviii, 32-37; Arch. Surg., 1937, xxxiv, 351-358. CrossrefGoogle Scholar13. LONGBLISS PHEA: The use of para-aminobenzenesulphonamide (sulphanilamide) or its derivatives in the treatment of infections due to beta hemolytic streptococci, pneumococci, and meningococci, South. Med. Jr., 1937, xxx, 479-487. CrossrefGoogle Scholar14. KLEERÖMER PH: Prontosil bei Streptokokkenerkrankungen, Deutsche. med. Wchnschr., 1935, lxi, 253-255. CrossrefGoogle Scholar15. SCHRANZ H: Zur Sepsisbehandlung mit Prontosil, München. med. Wchnschr., 1935, lxxxii, 419-420. Google Scholar16. RECKNAGEL K: Erfahrungen mit Prontosil, München. med. Wchnschr., 1935, lxxxii, 704-706. Google Scholar17. HOFMANN E: Erfahrungen mit Prontosil bei septischen Erkrankungen, Fortschr. Ther., 1935, xi, 762. Google Scholar18. SCHEURER O: Unsere Erfahrungen mit Prontosil, Med. Klinik, 1936, lxxxiii, 739-742. Google Scholar19. DAVIS ED: Acute streptococcal infections of the throat, Lancet, 1936, 375-376. Google Scholar20. ROBERTS SE: Will prontosil master streptococcus? Kansas City Med. Jr., 1937, xiii, 4-7. Google Scholar21. SCHURSINGER MK: Ein Fall von geheilter septischer Agranulocytose, Wien. med. Wchnschr., 1937, lxxxvii, 186. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Brooklyn, New York*Presented before the Staff Meeting of the Bay Ridge Hospital, Brooklyn, New York, May 4, 1937. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDie aplastischen und hypoplastischen Myelopathien (Knochenmarksaplasien) 1 December 1938Volume 12, Issue 6Page: 882-887KeywordsAnginaChemotherapeutic agentsPharyngitisStreptococcal infections Issue Published: 1 December 1938 PDF downloadLoading ...